Answers are grounded in this paper and cite their sources.
, suggesting that a different mechanism of action is engaged. These findings support the potential of this dual-targeting approach through a dual-targeting SMDC as a promising therapeutic strategy against high-grade glioma overexpressing the α5β1 integrin receptor.
No takes yet. Share an insight, caveat, or question.
Arrigoni et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: